Skip to main content
Quest Diagnostics

Patterns of Prostate Specific Antigen (PSA) Testing and Prostate Biopsy During the Coronavirus Disease 2019 Pandemic

Patterns of Prostate Specific Antigen (PSA) Testing and Prostate Biopsy During the Coronavirus Disease 2019 Pandemic

Authors: Kaufman HW, Chen Z, Niles JK, Radcliff R, Fesko Y

Citation: JCO Clin Cancer Inform. 2021 Sep;5:1028-1033. doi: 10.1200/CCI.21.00074.

Specialties: Infectious Disease, COVID-19, Oncology

Download key summary

Related content

Publication
New Cancer Diagnoses Still Lagging in the United States in Second Full Year of COVID-19 Pandemic
Publication
Patterns of Prostate Specific Antigen Testing and Prostate Biopsies during the COVID 19 Pandemic in the United States
Publication
A Pilot Feasibility Study of Digital Health Coaching for Men With Prostate Cancer
Conference Presentation
AI-Empowered Digital Workflow for Prostate Pathology in Clinical Routine: A Reader Study for Prostate Biopsies

Our company

Quest® is the brand name used for services offered by Quest Diagnostics Incorporated and its affiliated companies. Quest Diagnostics Incorporated and certain affiliates are CLIA certified laboratories that provide HIPAA covered services.  Other affiliates operated under the Quest® brand, such as Quest Consumer Inc., do not provide HIPAA covered services. 

 

Quest®, Quest Diagnostics®, any associated logos, and all associated Quest Diagnostics registered or unregistered trademarks are the property of Quest Diagnostics. All third-party marks—® and ™—are the property of their respective owners. © 2024 Quest Diagnostics Incorporated. All rights reserved. Image content features models and is intended for illustrative purposes only.